谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

P78.05 Patterns of Irae During First Line Pembrolizumab for NSCLC: Incidence, Risk Factors, and Impact on Clinical Outcome

C. Wood,G. Lopez, L. Zhao,M. Li,N. Surya,S. Patel,M. Grogan,E. Bertino,P. Shields,K. He,D. Carbone,G. Otterson,C. Presley, B. Pannecouk,G. Kalemkerian,B. Schneider,S. Gadgeel,N. Ramnath,D. Owen,A. Qin

Journal of Thoracic Oncology（2021）

引用 0|浏览27
暂无评分
关键词
Pembrolizumab,immune related adverse events,Non small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要